Abstract:Diabetic neuropathy is one of the prevalent and debilitating microvascular complications of diabetes mellitus, affecting a significant portion of the global population. Relational preclinical animal models are essential to understand its pathophysiology and develop effective treatments. This abstract provides an overview of current knowledge and advancements in such models. Various animal models have been developed to mimic the multifaceted aspects of human diabetic neuropathy, including both type 1 and type 2 diabetes. These models involve rodents (rats and mice) and larger animals like rabbits and dogs. Induction of diabetic neuropathy in these models is achieved through chemical, genetic, or dietary interventions, such as diabetogenic agents, genetic modifications, or high-fat diets. Preclinical animal models have greatly contributed to studying the intricate molecular and cellular mechanisms underlying diabetic neuropathy. They have shed light on hyperglycemia-induced oxidative stress, neuroinflammation, mitochondrial dysfunction, and altered neurotrophic factor signaling. Additionally, these models have allowed for the investigation of morphological changes, functional alterations, and behavioral manifestations associated with diabetic neuropathy. These models have also been crucial for evaluating the efficacy and safety of potential therapeutic interventions. Novel pharmacological agents, gene therapies, stem cell-based approaches, exercise, dietary modifications, and neurostimulation techniques have been tested using these models. However, limitations and challenges remain, including physiological differences between humans and animals, complex neuropathy phenotypes, and the need for translational validation. In conclusion, preclinical animal models have played a vital role in advancing our understanding and management of diabetic neuropathy. They have enhanced our knowledge of disease mechanisms, facilitated the development of novel treatments, and provided a platform for translational research. Ongoing efforts to refine and validate these models are crucial for future treatment developments for this debilitating condition.

[Research Progress on the Animal Models and Treatment Strategies of Diabetic Foot Ulcer].

Murine Models of Vascular Endothelial Injury: Techniques and Pathophysiology

Preclinical study of diabetic foot ulcers: From pathogenesis to vivo/vitro models and clinical therapeutic transformation

Application of Animal Models in Diabetic Cardiomyopathy

Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy

Stem Cell-Based Therapy for Diabetic Foot Ulcers

Male or female sex: considerations and translational aspects in diabetic foot ulcer research using rodent models

Experimental treatments in clinical trials for diabetic foot ulcers: wound healers in the pipeline

Progress in Medical Therapy for Diabetic Foot Ulcer

Effect of matrix metalloproteinases on the healing of diabetic foot ulcer: A systematic review

Diabetic neuropathy research: from mouse models to targets for treatment

Recent advances in the adjunctive management of diabetic foot ulcer: Focus on noninvasive technologies

Role of microRNAs in diabetic foot ulcers: Mechanisms and possible interventions

Advances in Zebrafish for Diabetes Mellitus with Wound Model

Advances in Murine Models of Diabetic Nephropathy

Difficulties in the Treatment of Diabetic Foot and Research Progress of Combination of Traditional Chinese and Western Medicine

Review on In-vitro Techniques and In-vivo Animals Models for Screening Diabetes and Diabetic Complications

Current advancement in the preclinical models used for the assessment of diabetic neuropathy

Treatment for Diabetic Peripheral Neuropathy: What have we Learned from Animal Models?

Animal experimental models of ischemic wounds – A review of literature

Efficiency of Stem Cell Based Therapy in the Treatment of Diabetic Foot Ulcer: a Meta-Analysis.